Beijing Key Laboratory for Genetics of Birth Defects, Beijing Pediatric Research Institute; MOE Key Laboratory of Major Diseases in Children, Capital Medical University; Center of Rare Diseases, National Center for Children's Health; Beijing Children's Hospital, Capital Medical University, Beijing, China.
Department of Cardiac Surgery, Beijing Anzhen Hospital, Beijing Institute of Heart, Capital Medical University, Lung and Blood Vessel Diseases, Beijing, China.
Genet Test Mol Biomarkers. 2024 Nov;28(11):431-437. doi: 10.1089/gtmb.2024.0139.
To identify genetic variants associated with Stanford A thoracic aortic aneurysm and dissection (ATAAD) using whole-exome sequencing (WES) and analyze positive mutation rates among patients of different onset ages. WES was performed on 62 sporadic Chinese ATAAD patients (51-74 years old), and then grouped based on onset age together with 73 previously reported TAAD patients (19-50 years old): ≤35, 36-45, 46-55, and >55 years. The proportion of patients with pathogenic/likely pathogenic (P/LP) variants in TAAD causal genes was compared across groups. The average onset age of the 62 patients was 57.66 years. Eight P/LP variants were identified (two novel, six previously described) in five known TAAD causal genes (, , , , and ) in eight individuals. P/LP variant positive rates among patients across age groups were: 22.73% for ≤35 years, 32% for 36-45 years, 15.52% for 46-55 years, and 3.33% for >55 years. Significant differences ( = 0.0077) were observed between 36-45 and >55 years group. ATAAD patients aged 36-45 years old at diagnosis had a higher chance of having a P/LP variant and patients >55 years old had the lowest P/LP diagnostic rate. Therefore, gene screening in ATAAD patients ≤55 years old is key to improved diagnostic rate.
为了使用全外显子组测序(WES)鉴定与斯坦福 A 型胸主动脉瘤和夹层(ATAAD)相关的遗传变异,并分析不同发病年龄患者的阳性突变率。对 62 例散发性中国 ATAAD 患者(51-74 岁)进行了 WES,然后根据发病年龄与 73 例先前报道的 TAAD 患者(19-50 岁)一起分组:≤35 岁、36-45 岁、46-55 岁和>55 岁。比较了不同组中 TAAD 因果基因中致病性/可能致病性(P/LP)变异的患者比例。62 例患者的平均发病年龄为 57.66 岁。在 8 名个体中,在五个已知的 TAAD 因果基因(、、、和)中发现了 8 个 P/LP 变体(两个新的,六个先前描述的)。各年龄组患者的 P/LP 变异阳性率为:≤35 岁为 22.73%,36-45 岁为 32%,46-55 岁为 15.52%,>55 岁为 3.33%。在 36-45 岁和>55 岁组之间观察到显著差异(=0.0077)。诊断为 36-45 岁的 ATAAD 患者发生 P/LP 变异的可能性更高,而>55 岁的患者发生 P/LP 诊断的几率最低。因此,≤55 岁的 ATAAD 患者的基因筛查是提高诊断率的关键。